Avalon Trust’s OptimizeRx OPRX Stock Holding History

Avalon Trust’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.6K	Hold	2,000	–	–	﹤0.01%	386
2025 Q4	$24.5K	Hold	2,000	–	–	﹤0.01%	342
2025 Q3	$41K	Hold	2,000	–	–	﹤0.01%	341
2025 Q2	$27K	Hold	2,000	–	–	﹤0.01%	307
2025 Q1	$17.3K	Hold	2,000	–	–	﹤0.01%	337
2024 Q4	$9.72K	Hold	2,000	–	–	﹤0.01%	319
2024 Q3	$15.4K	Hold	2,000	–	–	﹤0.01%	274
2024 Q2	$20K	Hold	2,000	–	–	﹤0.01%	263
2024 Q1	$24.3K	Hold	2,000	–	–	﹤0.01%	263
2023 Q4	$28.6K	Hold	2,000	–	–	﹤0.01%	241
2023 Q3	$15.6K	Hold	2,000	–	–	﹤0.01%	245
2023 Q2	$28.6K	Hold	2,000	–	–	﹤0.01%	233
2023 Q1	$29.3K	Buy	+2,000	New	+$33.5K	﹤0.01%	225

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avalon Trust's OPRX Position: Q1 2026 in Review

Avalon Trust held its OptimizeRx (OPRX) position steady in Q1 2026 at 2,000 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #386.

Avalon Trust first reported a position in OPRX in Q1 2023 and has held it in 13 quarters since. The position peaked at $41K in Q3 2025. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

Avalon Trust held 2,000 shares of OptimizeRx worth $12.6K as of Q1 2026.
Avalon Trust left its OptimizeRx share count unchanged in Q1 2026.
OptimizeRx made up ﹤0.01% of Avalon Trust's portfolio in Q1 2026, its #386 holding.
Avalon Trust first reported a position in OptimizeRx in Q1 2023 and has held it in 13 quarters since.
Avalon Trust's OptimizeRx position peaked at $41K in Q3 2025.
127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.